Moran Wealth Management LLC increased its holdings in shares of ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO – Free Report) by 39.2% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 29,348 shares of the company’s stock after buying an additional 8,264 shares during the quarter. Moran Wealth Management LLC’s holdings in ALPS Medical Breakthroughs ETF were worth $1,536,000 at the end of the most recent reporting period.
Other large investors have also bought and sold shares of the company. Jones Financial Companies Lllp bought a new position in ALPS Medical Breakthroughs ETF in the first quarter valued at about $782,000. Raymond James Financial Inc. bought a new position in shares of ALPS Medical Breakthroughs ETF in the second quarter worth about $82,000. Comerica Bank acquired a new stake in shares of ALPS Medical Breakthroughs ETF in the 3rd quarter valued at approximately $27,000. Virtu Financial LLC acquired a new stake in shares of ALPS Medical Breakthroughs ETF in the 3rd quarter valued at approximately $650,000. Finally, Fulcrum Equity Management bought a new stake in shares of ALPS Medical Breakthroughs ETF during the 4th quarter valued at approximately $384,000.
ALPS Medical Breakthroughs ETF Trading Up 1.8%
Shares of ALPS Medical Breakthroughs ETF stock traded up $1.15 during midday trading on Tuesday, hitting $65.99. 20,938 shares of the company traded hands, compared to its average volume of 35,750. The firm’s fifty day moving average price is $55.46 and its 200-day moving average price is $53.02. ALPS Medical Breakthroughs ETF has a 12 month low of $30.40 and a 12 month high of $66.68.
About ALPS Medical Breakthroughs ETF
The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.
See Also
- Five stocks we like better than ALPS Medical Breakthroughs ETF
- GE Vernova’s Power Surge Turns the Grid Into an AI Trade
- Orbiting Capital: Lawmakers Buy SpaceX Ahead of Index Inclusion
- Big Beautiful Boycott: Can It Really Hurt Coca-Cola, Amazon, and Kraft Heinz Stocks?
- 3 Stocks With Solid Yields and Sustainabale Payouts Boost Dividends Once Again
Want to see what other hedge funds are holding SBIO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO – Free Report).
Receive News & Ratings for ALPS Medical Breakthroughs ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Medical Breakthroughs ETF and related companies with MarketBeat.com's FREE daily email newsletter.
